Repro Med Systems Inc (REPR)

[blue_skies]

mr. i was slightly disappointed to see revenue did not make 20%. If i had to guess, I think rms will earn slightly more then a penny a share?

buyout will come. to get full value company will have to demonstrate rms infusion products work in new market first. this is happening now and will continue. when i read the new ceo resume it is much more investor friendly and consequently rms will get the visibility it deserves. rms has been flying under the radar for a long time and this is about to change

One thing not talked about much is that the rms infusion devices have a superior flow profile. its more even flow rate throughout the infusion. its done at a lower pressure. And generally administered via smaller needle sizes which is important for patient comfort.

nice pop tuesday at end of day. could not find any news